eLife

eLife is a unique collaboration between funders and practitioners of research to communicate influential discoveries in the life and biomedical sciences in the most effective way. It is launched with support from the Howard Hughes Medical Institute, the Wellcome Trust, and the Max Planck Society in November 2012. eLife represents a new model of scientific publishing, designed to meet the needs of scientists in life sciences and biomedicine in a better way. This includes free, immediate, online access to scientific articles; rapid, fair, and constructive review; and innovation in content presentation – in short, a journal for scientists, run by scientists. Initial decisions are made by eLife’s senior editors, and, if a submission is selected for further assessment, full peer review is overseen by eLife’s 175-member board of reviewing editors. The reviewing editor and reviewers consult once peer review comments are submitted, and provide a consolidated list of instructions to authors – eliminating unnecessary and time-consuming rounds of revision.

Publisher
eLife Sciences Publications, Ltd
Website
http://www.elifesciences.org/

Some content from Wikipedia, licensed under CC BY-SA

Neuroscience

Exposure to smells in early infancy can modulate adult behavior

Imprinting is a popularly known phenomenon, wherein certain animals and birds become fixated on sights and smells they see immediately after being born. In ducklings, this can be the first moving object, usually the mother ...

Medical research

Dendritic computers: When 1 + 1 = 3

The human brain is jampacked with neurons—86 billion of them—connected in a vast, complex network that controls how we move, think, talk and make memories. Vital information is exchanged across this network through trillions ...

Psychology & Psychiatry

How people decide when they have so many choices

It's one thing to decide among two or three snacks available at a friend's house. But what do people do when they're faced with a vending machine offering 36 different options?

Immunology

Novel biomarker for glucocorticoids could help tailor treatments

Researchers have uncovered pathways involved in the body's response to glucocorticoid treatments and identified a novel biomarker that could be used to monitor how these drugs work in patients, according to a clinical study ...

page 1 from 26